TQB2916 plus chemo or penpulimab for sarcoma or melanoma
Part of Cancer, Skin clinical trials.
This trial tests a new drug (TQB2916) combined with either chemotherapy or another immunotherapy (penpulimab) for advanced soft tissue sarcomas or melanoma. It aims to see if the combination shrinks tumors or slows cancer growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a type of soft tissue sarcoma (like liposarcoma, leiomyosarcoma, or undifferentiated pleomorphic sarcoma) or melanoma that cannot be removed by surgery or has spread.
- You have not had certain treatments before, depending on your cancer type: for liposarcoma or leiomyosarcoma, you have not had too much doxorubicin; for undifferentiated pleomorphic sarcoma, you have had at most 2 types of antiangiogenic pills and not certain immunotherapy drugs.
- You are healthy enough to be up and about (ECOG score 0 or 1) and your organs are working well.
- You agree to use birth control during and for 6 months after the study, if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of immunotherapy (atezolizumab), chemotherapy (doxorubicin), and radiation before and after surgery for people with high-risk soft tissue sarcoma in the arm, leg, or trunk. The goal is to see if this approach can improve outcomes.
This trial tests a new drug, TQB6411, for people with advanced cancers that have not responded to standard treatments. It aims to see if the drug is safe and effective for different tumor types.
This study tests a new injection called TQB2930 designed to treat advanced solid cancers (cancers that have spread) that have HER2 protein on their surface. The goal is to see if this treatment can shrink these tumors and help patients live longer.
This trial tests a new drug (TQB2916) combined with standard chemotherapy (gemcitabine and nab-paclitaxel) as a first treatment for metastatic pancreatic cancer. It aims to see if the combination works better than chemo alone.
This trial tests an experimental oral capsule called TQB3019 for people with advanced blood cancers that have come back or not improved with other treatments. The goal is to see if the drug is safe and to find the right dose.
This trial tests a new drug called TQB6426 for people with advanced solid tumors that have not responded to other treatments. The drug targets a protein called GPC3 found on some tumors, aiming to deliver a powerful therapy directly to the cancer cells.
Hear when a new Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.